Michael Yee, BioTech Analyst, RBC Capital Markets, on why shares of Gilead are up 12 percent so far this year.» Read More
Amazon could be the next hedge fund darling, but is the trade too crowded, with Pavle Sabic, S&P Capital IQ.
CNBC's David Faber reports that one hedge fund is making a major bet on aluminum giant, Alcoa.
CNBC's Kate Kelly follows the smart money and highlights which names are most popular with hedge funds.
Activist investor Carl Icahn turned up the pressure on American International Group to separate into three public companies.
Paul Singer's Elliott Management will disclose a 6.5 percent stake in Alcoa, sources tell CNBC.
More and more investors appear to be pulling out of hedge funds, reports CNBC's Kate Kelly.
Investors flagged their intention to shift more money out of hedge funds in November as they adjusted positions before the year-end, data showed.
At a time when solid returns of any sort are hard to come by, it's not surprising to see market participants reaching for risk.
BlackRock has become the latest investment house to close a macro hedge fund after its $1bn vehicle suffered its worst-ever performance, the FT reports.
As many market participants focused on the increased chances for an interest rate hike, hedge fund managers were loading up on government debt.
Apple shares also declined 12 percent during the third quarter.
Leon Cooperman's Omega Advisors liquidated its stake in Valeant Pharmaceuticals, reports CNBC's Dom Chu.
Major hedge fund managers disclosed third-quarter holdings, reports CNBC's Kate Kelly.
CNBC Senior Markets Commentator Michael Santoli discusses pain for hedge fund managers and what it could mean for retail investors.
NCR under scrutiny from activist investor PSAM over Blackstone deal.
Avenue Capital Group is shutting down its original hedge fund, Avenue Investments, and returning money to investors.
Mark Farrington, head of Macro Currency, discusses the possibility of a spike in volatility ahead of the Federal Reserve's December meeting.
Just as it seemed like 2015 would be a total wipeout for hedge funds, October brought the industry some life.
Pershing Square's Bill Ackman has sent a letter to Valeant Chairman and CEO Michael Pearson, expressing support of his leadership.
Dow Chemical CEO Andrew Liveris has been meeting with influential portfolio managers about the company's long-term strategy.